Gotowe bibliografie tematyczne / Ophthalmic pharmaceuticals

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji

Gotowa bibliografia na temat „Ophthalmic pharmaceuticals”

Autor: Grafiati
Data publikacji: 3 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Ophthalmic pharmaceuticals”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Ophthalmic pharmaceuticals"

1

Md., Sahab Uddin, Al Mamun Abdullah, Tanvir Kabir Md., et al. "Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications." Journal of Advances in Medical and Pharmaceutical Sciences 14, no. 2 (2017): 1–17. https://doi.org/10.9734/JAMPS/2017/33924.

Pełny tekst źródła
Streszczenie:
The therapeutically performance of the pharmaceuticals must be constant and expectable. In order to claim a pharmaceutical to be a quality drug, it must fulfill certain standards and specifications. The quality of pharmaceuticals is strongly related to the patient’s well-being. Quality control (QC) is an historical process in which proof is obtained that the appropriate level of quality has been achieved. QC can have no effect on the quality of the pharmaceuticals. It is merely a measuring process. QC must ensure that all the finished products contain active ingredients that comply with the qu
Style APA, Harvard, Vancouver, ISO itp.
2

Clarkson, Douglas. "Nanotechnology in ophthalmology: An update." Optician 2017, no. 7 (2017): 6603–1. http://dx.doi.org/10.12968/opti.2017.7.6603.

Pełny tekst źródła
Streszczenie:
Developments in nanotechnology present new opportunities in treatment of ocular disease and in the evolution of ophthalmic pharmaceuticals. Dr Douglas Clarkson offers an update on this new area of healthcare.
Style APA, Harvard, Vancouver, ISO itp.
3

Meagher, Andrew, and G. Richard Bennett. "Klinische Anwendung von Rhopressa: Eine Fallserie." Optometry & Contact Lenses 3, no. 1 (2022): 20–29. http://dx.doi.org/10.54352/dozv.xqja4215.

Pełny tekst źródła
Streszczenie:
Purpose. The aim of this paper is to discuss and highlight via case reports the effective use of Rhopressa in three individual cases of Primary Open-Angle Glaucoma (POAG) treated at a glaucoma clinic in Philadelphia, PA, USA. The cases display the clinical use of netarsudil and reviews therapeutic approach- es to combating the side effects of conjunctival hyperemia associated with netarsudil. Material and Methods. A systematized PubMed literature search based on the terms “Rhopressa”, “netarsudil”, “ROCK inhibition” was conducted. Six eyes of three adult patients were monitored for three month
Style APA, Harvard, Vancouver, ISO itp.
4

Uddin, Md, Abdullah Mamun, Md Kabir, et al. "Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications." Journal of Advances in Medical and Pharmaceutical Sciences 14, no. 2 (2017): 1–17. http://dx.doi.org/10.9734/jamps/2017/33924.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Papava, Medea V., and Nana J. Gaprindashvili. "The Efficacy and Safety of Topical Cyclosporine A and its Generic Equivalency Depores Eye Drops in The Treatment of Dry Eye Disease." Caucasus Journal of Medical and Psychological Sciences 2, no. 1-2 (2024): 50–68. http://dx.doi.org/10.61699/cjmps-v2-i1-2-p50-68.

Pełny tekst źródła
Streszczenie:
Dry eye disease (DED) is a complex condition that can result in significant vision complications. Analyzing systematic reviews of DED treatment contributes to selecting the most effective and safe drug. This review examines the efficacy of cyclosporine A and the generic Depores ophthalmic emulsion cyclosporine 0.05% (cyclosporine 0.05%, Deva Pharmaceuticals, Turkey) in the treatment of DED. A search for scientific information in PubMed, PubMed Central, The Cochrane Library, Google Scholar databases, and the Internet was carried out using keywords: dry eye disease, Cyclosporine A, Ikervis, Rest
Style APA, Harvard, Vancouver, ISO itp.
6

Inam, Onur, Ersin Demir, and Bengi Uslu. "Voltammetric Pathways for the Analysis of Ophthalmic Drugs." Current Pharmaceutical Analysis 16, no. 4 (2020): 367–91. http://dx.doi.org/10.2174/1573412915666190225163637.

Pełny tekst źródła
Streszczenie:
Background: This review investigates the ophthalmic drugs that have been studied with voltammetry in the web of science database in the last 10 years. Introduction: Ophthalmic drugs are used in the diagnosis, evaluation and treatment of various ophthalmological diseases and conditions. A significant literature has emerged in recent years that investigates determination of these active compounds via electroanalytical methods, particularly voltammetry. Low cost, rapid determination, high availability, efficient sensitivity and simple application make voltammetry one of the most used methods for
Style APA, Harvard, Vancouver, ISO itp.
7

VYAS, URVASHI, NARENDRA GEHALOT, VIKAS JAIN, and S. C. MAHAJAN. "A REVIEW ON IN SITU GELLING SYSTEM FOR OPHTHALMIC DRUG DELIVERY." Current Research in Pharmaceutical Sciences 11, no. 4 (2022): 98–106. http://dx.doi.org/10.24092/crps.2021.110402.

Pełny tekst źródła
Streszczenie:
Ophthalmic drug delivery systems are both fascinating and problematic due to the normal physiological properties of the eyes, which restrict ocular product bioavailability. The development of novel ocular dosage forms for current drugs in order to enhance efficacy and bioavailability, as well as patient compliance and convenience, has become a major focus in the pharmaceutical business. Ocular In-situ gelling systems are a novel type of eye drug delivery systems that begin as a solution but rapidly convert into a thick gel when implanted or inserted into an ocular cavity where active pharmaceu
Style APA, Harvard, Vancouver, ISO itp.
8

Abdelkader, H., B. Pierscionek, M. Carew, Z. Wu, and R. G. Alany. "Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals." British Medical Bulletin 113, no. 1 (2015): 59–71. http://dx.doi.org/10.1093/bmb/ldv002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Cable, Melissa Morrison. "Review of Bromfenac Ophthalmic Solution 0.09 % Once-daily." US Ophthalmic Review 05, no. 01 (2012): 37. http://dx.doi.org/10.17925/usor.2012.05.01.37.

Pełny tekst źródła
Streszczenie:
Bromfenac ophthalmic solution 0.09 % (BROMDAY™, ISTA Pharmaceuticals, Inc., Irvine, CA) is the first and only once-daily topical ophthalmic non-steroidal anti-inflammatory drug (NSAID) approved by the Food and Drug Administration for the treatment of post-operative pain and inflammation following cataract surgery. Topical NSAIDs are important following surgery to enhance patient comfort and limit inflammation, which may otherwise restrict visual rehabilitation. In a recently published study looking at Early Treatment Diabetic Retinopathy Study (ETDRS) acuities and macular optical computed tomo
Style APA, Harvard, Vancouver, ISO itp.
10

Ergen, Harun, Muge Guleli, Cigdem Sener, Cem Caliskan, Sercan Semiz, and Mahmut Ozbek. "Development and Validation of a Novel Reversed Phase High Performance Liquid Chromatography with Refractive Index Detector Method for Assay of Polyvinyl Alcohol in an Ophthalmic Solution." Current Pharmaceutical Analysis 16, no. 7 (2020): 867–71. http://dx.doi.org/10.2174/1573412915666190304152901.

Pełny tekst źródła
Streszczenie:
Introduction: Polyvinyl alcohol (PVA), a polymer, is in demand due to its usage in different applications such as pharmaceutical, biomedical and textile, paper, food industries. Methods: A new sensitive reversed phased high-pressure liquid chromatography (RP-HPLC) method with refractive index detector (RID) was developed for determination of PVA in an ophthalmic solution containing dexpanthenol and PVA as active substances and it was validated according to The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline. Results: Chromatog
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Ophthalmic pharmaceuticals"

1

Zachar, Carrie L. "Pharmaceutically Relevant Microemulsions with Potential Topical, Ophthalmic, and Parenteral Applications." University of Toledo / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1271273404.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Fitzgerald, P. "An assessment of the precorneal residence of ophthalmic drug delivery systems." Thesis, University of Nottingham, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.356556.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Meslard, Jean-Claude. "Immobilisation temporaire de medicaments par des liaisons hydrolysables sur des polymeres biocompatibles : application a l'ophtalmologie." Paris 6, 1988. http://www.theses.fr/1988PA066417.

Pełny tekst źródła
Streszczenie:
L'objectif est l'immobilisation reversible de medicaments (chloramphenicol, indometacine) au sein de lentilles de contact hydrophiles permettant une liberation lente et continue lors de leur adaptation sur des yeux malades
Style APA, Harvard, Vancouver, ISO itp.

Książki na temat "Ophthalmic pharmaceuticals"

1

Dornic, Dean. Ophthalmic pocket companion. 5th ed. Butterworth-Heinemann, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Frost & Sullivan., ed. World ophthalmic pharmaceutical markets: Technology-driven products for shifting global economies. Frost & Sullivan, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Rhee, Douglas J. The Wills eye drug guide: Diagnostic and therapeutic medications. Lippincott-Raven, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Optometry, Virginia Board of, Virginia Board of Pharmacy, and Virginia. Dept. of Health Professions., eds. Regulations of the Virginia Board of Optometry, title of regulations 18 VAC 105-20-10 et seq., effective date January 15, 2003: Statutes relating to the practice of optometry, 2002 ; regulations for certification for therapeutic pharmaceutical agents, title of regulations 18 VAC 105-20-10 et seq., effective date January 15, 2003 ; drug laws for TPA certified optometrists. Dept. of Health Professions, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bartlett, Jimmy D. Od. Ophthalmic Drug Facts 2001 (Ophthalmic Drug Facts). Facts and Comparisons, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mitra, Ashim K. Ophthalmic Drug Delivery Systems, Second Edition (Drugs and the Pharmaceutical Sciences). 2nd ed. Informa Healthcare, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bartlett, Jimmy D. Ophthalmic Drug Facts, 2000. Facts and Comparisons, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

(Philadelphia, Pa ). Wills Eye Hospital. The Wills Eye Drug Guide: Diagnostic and Therapeutic Medications. 2nd ed. Lippincott Williams & Wilkins, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Ophthalmic pharmaceuticals"

1

Wilson, Clive G. "Chapter 1. Ophthalmic Formulation." In Specialised Pharmaceutical Formulation. Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839165603-00001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Bhawale, Rohit, Vaibhavi Srivastava, and Neelesh Kumar Mehra. "Advances in Ophthalmic Formulation Development." In Advances in Pharmaceutical Product Development. Springer Nature Singapore, 2025. https://doi.org/10.1007/978-981-97-9230-6_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Brunaugh, Ashlee D., Hugh D. C. Smyth, and Robert O. Williams III. "Ophthalmic and Otic Drug Delivery." In AAPS Introductions in the Pharmaceutical Sciences. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-31745-4_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Brunaugh, Ashlee D., Daniel Moraga-Espinoza, Tania Bahamondez-Canas, Hugh D. C. Smyth, and Robert O. Williams. "Ophthalmic and Otic Drug Delivery." In AAPS Introductions in the Pharmaceutical Sciences. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-52520-9_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Sharma, Sandeep, Varsha Narayanan, Manoj Mahajan, and Y. S. V. S. Naga Mohan. "Ophthalmic Pharmaceutical Markets South-East Asia Region Perspective 2020." In South-East Asia Eye Health. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3787-2_35.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Suri, Reshal. "Design of Experiments for the Development of Ophthalmic Products." In Design of Experiments for Pharmaceutical Product Development. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4351-1_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Müller-Goymann, Christel C., and Mukta Paranjpe. "Nanodrugs in Medicine and Healthcare: Pulmonary, Nasal and Ophthalmic Routes, and Vaccination." In Pharmaceutical Nanotechnology: Innovation and Production. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527800681.ch26.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Deepika, B., Rajini Kolure, B. Uma Rajeshwari, P. Naga Haritha, and B. Suhasini. "Evaluation of the Relationship between Ocular Damage and Monocular Blindness Related to Ophthalmic Illness." In Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences. CRC Press, 2025. https://doi.org/10.1201/9781003618140-163.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Herrero-Vanrell, Rocío. "Ophthalmic Pharmaceuticals: New Formulations." In Ocular Pharmacotherapy. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/12924_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

DOUGHTY, M. "Ophthalmic pharmaceuticals, their formulation and use." In Ocular Pharmacology & Therapeutics. Elsevier, 2001. http://dx.doi.org/10.1016/b978-0-7506-4520-1.50008-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Ophthalmic pharmaceuticals"

1

Sandhu, Jaspal S., Aman Bhandari, Mahad Ibrahim, and P. Balakrishnan. "Appropriate Design of Medical Technologies for Emerging Regions: The Case of Aurolab." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-81291.

Pełny tekst źródła
Streszczenie:
Healthcare delivery in emerging regions presents a unique set of challenges and is characterized largely by poor infrastructure. Though there is significant variation from country to country - and even within countries - in emerging regions, common themes emerge, such as overreliance on direct payment schemes, unreliable supply chains, and intermittent power in rural settings. These themes in turn impose particular design requirements on manufacturers of medical devices and pharmaceuticals; this paper focuses on these design requirements. We illustrate the importance of designing specifically
Style APA, Harvard, Vancouver, ISO itp.
2

L. Kiss, Eszter, Erzsébet Csányi, and Mária Budai-Szűcs. "Nanostructured lipid carriers for ophthalmic use." In II. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2020. http://dx.doi.org/10.14232/syrptbrs.2020.op16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Szalai, Boglárka, Orsolya Jójárt-Laczkovich, and Mária Budai-Szűcs. "Evaluation of combined thermoresponsive ophthalmic gels." In VI. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2024. http://dx.doi.org/10.14232/syrptbrs.2024.22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

L. Kiss, Eszter, Mária Budai-Szűcs, and Erzsébet Csányi. "Mucoadhesive nanostructured lipid carriers for ophthalmic use." In III. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2021. http://dx.doi.org/10.14232/syrptbrs.2021.op15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bíró, Tivadar, and Zoltán Aigner. "Novel ophthalmic formulations to increase the efficacy and stability." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

L. Kiss, Eszter, Mária Budai-Szűcs, and Erzsébet Csányi. "Improving the ophthalmic bioavailability of steroidal anti-inflammatory drugs." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Victoria, Díaz, García Xurxo, Varela Rubén, Blanco Guillermo, Fernández Anxo, and Otero Francisco J. "<em>In vitro</em> and <em>in vivo</em> ophthalmic bioadhesion and ocular safety characterization of cyclodextrin based solution." In The 1st International Electronic Conference on Pharmaceutics. MDPI, 2020. http://dx.doi.org/10.3390/iecp2020-08789.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Ophthalmic pharmaceuticals” dla poszczególnych typów źródeł:
Artykuły w czasopismach
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii